$0.65
Last updated on
The stock has been delisted from the stock exchange on 17 Jul 2025
Check the interactive Brainstorm Cell Therapeutics Inc Stock chart to analyse performance
Check Brainstorm Cell Therapeutics Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Name
Holdings %
Armistice Capital, LLC
7.02%
CALDWELL SUTTER CAPITAL INC
1.60%
Geode Capital Management, LLC
0.59%
Vanguard Group Inc
0.28%
BlackRock Inc
0.26%
Liberty Wealth Management, LLC
0.23%
Sell
0%Buy
50%Hold
50%Sell
Based on 6 Wall street analysts offering stock ratings for Brainstorm Cell Therapeutics Inc(by analysts ranked 0 to 5 stars)
Brainstorm Cell Therapeutics Inc share price today is $0.65 as on at the close of the market. Brainstorm Cell Therapeutics Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.
Brainstorm Cell Therapeutics Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Brainstorm Cell Therapeutics Inc stock price today i.e. is closed at $0.65, lower by 89.68% versus the 52 week high.
Indian investors can start investing in Brainstorm Cell Therapeutics Inc (BCLI) shares with as little as ₹87.521 or $1 (as of August 23, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Brainstorm Cell Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on August 23, 2025).
Based on Brainstorm Cell Therapeutics Inc share’s latest price of $0.65 as on July 17, 2025 at 12:00 AM IST, you will get 15.3846 shares of Brainstorm Cell Therapeutics Inc. Learn more about
fractional shares .
Brainstorm Cell Therapeutics Inc stock has given 0.0% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?
$8.95
+0.56%
$12.27
+1.4%
$50.47
+5.04%
$26.80
+0.75%
$3.14
-2.18%
$4.85
+6.13%
$15.38
+14.35%
$10.37
-0.19%
$136.47
-0.76%